Pharmaceuticals

FDA Approves Verona’s Otovile for Maintenance Treatment of Chronic Obstructive Pulmonary Disease

bexib
By bexib 0 Min Read

OTOVIRE is the first inhaled medication approved in 20 years with a new mechanism of action for chronic obstructive pulmonary disease.

You Might Also Like

FDA Approves Johnson & Johnson’s Darzalex Faspro in Combination with Bortezomib, Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed Multiple Myeloma

Pharma Pulse 6/10/24: How Serious Are You About Patient-Centricity? Mark Cuban Talks Drug Prices and More

New study reveals how brain cell communication is linked to Alzheimer’s disease

FDA Grants Fast Track Designation to Clarity Pharmaceuticals’ Novel Treatment for PSMA-Positive Prostate Cancer Lesions

Brave biotech threatens Pfizer’s dominance of Prevnar vaccine market

Share This Article
Previous Article How To Start an LLC in Tennessee (2024)
Next Article Halstead appointed president of Canadian Grains Council – RealAgriculture
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

dtcpay and BNB Chain power the ecosystem for real-world stablecoin usage
Fintech
The Path Forward – Machine Insider
Manufacturing
How India’s UPI makeover and WhatsApp Pay expansion will transform banking
Fintech
Navigating innovation and sustainability in metal cutting
Manufacturing